{"id":"https://openalex.org/W2104192242","doi":"https://doi.org/10.1517/13543784.2011.629604","title":"Belinostat: clinical applications in solid tumors and lymphoma","display_name":"Belinostat: clinical applications in solid tumors and lymphoma","publication_year":2011,"publication_date":"2011-11-03","ids":{"openalex":"https://openalex.org/W2104192242","doi":"https://doi.org/10.1517/13543784.2011.629604","mag":"2104192242","pmid":"https://pubmed.ncbi.nlm.nih.gov/22046971"},"language":"en","primary_location":{"id":"doi:10.1517/13543784.2011.629604","doi":"https://doi.org/10.1517/13543784.2011.629604","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.2011.629604","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074632224","display_name":"Lulama Rhoda Molife","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"L Rhoda Molife","raw_affiliation_strings":["Drug Development Unit, Division of Clinical Sciences, The Institute of Cancer Research/The Royal Marsden, Downs Road, Sutton, Surrey, SM2 5PT, UK ; ;","+44 208 642 7979","Drug Development Unit, Division of Clinical Sciences, The Institute of Cancer Research/The Royal Marsden, Downs Road, Sutton, Surrey, SM2 5PT, UK +44 208 722 4303"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Division of Clinical Sciences, The Institute of Cancer Research/The Royal Marsden, Downs Road, Sutton, Surrey, SM2 5PT, UK ; ;","institution_ids":["https://openalex.org/I142947616"]},{"raw_affiliation_string":"+44 208 642 7979","institution_ids":[]},{"raw_affiliation_string":"Drug Development Unit, Division of Clinical Sciences, The Institute of Cancer Research/The Royal Marsden, Downs Road, Sutton, Surrey, SM2 5PT, UK +44 208 722 4303","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Johann S de Bono","raw_affiliation_strings":["Drug Development Unit, Division of Clinical Sciences, The Institute of Cancer Research/The Royal Marsden, Downs Road, Sutton, Surrey, SM2 5PT, UK ; ;","+44 208 642 7979","Drug Development Unit, Division of Clinical Sciences, The Institute of Cancer Research/The Royal Marsden, Downs Road, Sutton, Surrey, SM2 5PT, UK +44 208 722 4303"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Division of Clinical Sciences, The Institute of Cancer Research/The Royal Marsden, Downs Road, Sutton, Surrey, SM2 5PT, UK ; ;","institution_ids":["https://openalex.org/I142947616"]},{"raw_affiliation_string":"+44 208 642 7979","institution_ids":[]},{"raw_affiliation_string":"Drug Development Unit, Division of Clinical Sciences, The Institute of Cancer Research/The Royal Marsden, Downs Road, Sutton, Surrey, SM2 5PT, UK +44 208 722 4303","institution_ids":["https://openalex.org/I142947616"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I142947616"],"apc_list":null,"apc_paid":null,"fwci":0.2324,"has_fulltext":false,"cited_by_count":44,"citation_normalized_percentile":{"value":0.18489378,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"20","issue":"12","first_page":"1723","last_page":"1732"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/belinostat","display_name":"belinostat","score":1.0},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/peripheral-t-cell-lymphoma","display_name":"peripheral T-cell lymphoma","score":0.875},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.9919999837875366},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.9100000262260437},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.8889999985694885},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.9950000047683716},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.7639999985694885}],"concepts":[{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.6878212690353394},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6842573881149292},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.62339186668396},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5692973732948303},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.44015079736709595},{"id":"https://openalex.org/C2776262904","wikidata":"https://www.wikidata.org/wiki/Q905901","display_name":"Vorinostat","level":5,"score":0.41175520420074463},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3382105529308319},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32408708333969116},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.21815702319145203},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21770599484443665},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17304962873458862},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.16637054085731506},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.06643277406692505},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006877","descriptor_name":"Hydroxamic Acids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006877","descriptor_name":"Hydroxamic Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006877","descriptor_name":"Hydroxamic Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006877","descriptor_name":"Hydroxamic Acids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016411","descriptor_name":"Lymphoma, T-Cell, Peripheral","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016411","descriptor_name":"Lymphoma, T-Cell, Peripheral","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D017322","descriptor_name":"Clinical Trials, Phase II as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1517/13543784.2011.629604","doi":"https://doi.org/10.1517/13543784.2011.629604","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.2011.629604","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmid:22046971","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22046971","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":73,"referenced_works":["https://openalex.org/W129008480","https://openalex.org/W160911776","https://openalex.org/W1511815964","https://openalex.org/W1567485746","https://openalex.org/W1895939501","https://openalex.org/W1920958927","https://openalex.org/W1949662878","https://openalex.org/W1966446643","https://openalex.org/W1967018540","https://openalex.org/W1968027087","https://openalex.org/W1971579914","https://openalex.org/W1975592953","https://openalex.org/W1975692560","https://openalex.org/W1989416622","https://openalex.org/W1990011854","https://openalex.org/W1991376723","https://openalex.org/W1996103159","https://openalex.org/W1998148704","https://openalex.org/W2005753547","https://openalex.org/W2007268478","https://openalex.org/W2009053040","https://openalex.org/W2013186220","https://openalex.org/W2013499751","https://openalex.org/W2017583298","https://openalex.org/W2019967976","https://openalex.org/W2020912062","https://openalex.org/W2026699787","https://openalex.org/W2030480738","https://openalex.org/W2034420402","https://openalex.org/W2035471279","https://openalex.org/W2039139796","https://openalex.org/W2050931169","https://openalex.org/W2051035457","https://openalex.org/W2051890772","https://openalex.org/W2052703240","https://openalex.org/W2053638053","https://openalex.org/W2060181250","https://openalex.org/W2064270734","https://openalex.org/W2064959533","https://openalex.org/W2065915399","https://openalex.org/W2074669585","https://openalex.org/W2079620992","https://openalex.org/W2080029028","https://openalex.org/W2083436950","https://openalex.org/W2087400050","https://openalex.org/W2095788199","https://openalex.org/W2099030380","https://openalex.org/W2100972878","https://openalex.org/W2102169774","https://openalex.org/W2105835610","https://openalex.org/W2110959000","https://openalex.org/W2112004353","https://openalex.org/W2116524169","https://openalex.org/W2128986224","https://openalex.org/W2140204965","https://openalex.org/W2142629029","https://openalex.org/W2149379768","https://openalex.org/W2150862707","https://openalex.org/W2152694994","https://openalex.org/W2156517973","https://openalex.org/W2158178080","https://openalex.org/W2158798428","https://openalex.org/W2161763646","https://openalex.org/W2162438863","https://openalex.org/W2243473585","https://openalex.org/W2246882137","https://openalex.org/W2277476376","https://openalex.org/W2283143950","https://openalex.org/W2396221502","https://openalex.org/W2461303727","https://openalex.org/W2556560476","https://openalex.org/W2564351495","https://openalex.org/W2577902534"],"related_works":["https://openalex.org/W2135668827","https://openalex.org/W2094899231","https://openalex.org/W1942332510","https://openalex.org/W1865726727","https://openalex.org/W1754523296","https://openalex.org/W7073885035","https://openalex.org/W619104891","https://openalex.org/W3038018311","https://openalex.org/W2243735979","https://openalex.org/W4253914909"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Histone":[1],"deacetylase":[2],"(HDAC)":[3],"inhibitors":[4],"have":[5],"recently":[6],"emerged":[7],"as":[8,28,112],"a":[9,29,80,113],"novel":[10],"and":[11,32,38,47,56,150,155],"active":[12],"class":[13,23],"of":[14,21,44,54,59,74,91,137,141,153,158,168],"anticancer":[15],"agents.":[16],"Belinostat":[17,100],"is":[18,95],"one":[19],"member":[20],"the":[22,42,72,123,132,135,151,166],"that":[24,140],"has":[25,101,119],"been":[26,120],"tested":[27],"single":[30,114],"agent":[31,115],"in":[33,41,84,106,116],"combination":[34,127],"with":[35],"other":[36,142],"chemotherapies":[37],"biological":[39],"agents":[40],"treatment":[43],"solid":[45,117],"tumors":[46,118],"lymphoma.":[48,87],"AREAS":[49],"COVERED:":[50],"A":[51],"literature":[52],"search":[53],"pre-clinical":[55],"clinical":[57,104],"studies":[58,67],"belinostat":[60,75],"was":[61],"performed.":[62],"The":[63,88],"data":[64],"from":[65,76,126],"these":[66],"were":[68],"analysed":[69],"to":[70,79,146,163],"summarise":[71],"progress":[73,165],"Phase":[77],"I":[78],"current":[81],"pivotal":[82],"trial":[83],"peripheral":[85],"T-cell":[86,107],"parallel":[89],"development":[90,167],"appropriate":[92],"biomarker":[93],"analysis":[94],"also":[96],"discussed.":[97],"EXPERT":[98],"OPINION:":[99],"demonstrated":[102],"significant":[103],"activity":[105,111,136,159],"lymphomas.":[108],"Although":[109],"its":[110],"less":[121],"compelling,":[122],"emerging":[124],"results":[125],"trials":[128],"are":[129],"promising.":[130],"However,":[131],"basis":[133],"for":[134],"belinostat,":[138],"like":[139],"HDAC":[143],"inhibitors,":[144],"remains":[145],"be":[147,161],"truly":[148],"defined":[149],"identification":[152],"predictive":[154],"prognostic":[156],"biomarkers":[157],"should":[160],"established":[162],"further":[164],"this":[169],"compound.":[170]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}